Literature DB >> 27306212

Post-intensive care unit syndrome in gynecologic oncology patients.

Camille C Gunderson1, Adam C Walter2, Rachel Ruskin2, Kai Ding3, Kathleen N Moore2.   

Abstract

PURPOSE: The purposes of the present study are to describe the demographic and treatment characteristics of women on the gynecologic oncology service who required intensive care and assess prevalence of risk factors for post-intensive care syndrome (PICS).
METHODS: A retrospective chart review was performed encompassing patients requiring admission to the intensive care unit (ICU) on the gynecology oncology service between 1/2008 and 12/2012. Descriptive statistics were computed using SAS version 9.3.
RESULTS: One hundred eleven patients met study criteria. Most were Caucasian (85 %), were married (50 %), and had stage III/IV disease (82 %). Risk factors for PICS were as follows: 9 % had baseline anxiety, 20 % had baseline depression, 21 % were taking an SSRI prior to admission, and 18 % took other psychiatric medications. Most ICU admissions (47 %) were for planned post-operative management. Thirty-seven percent required mechanical ventilation for a median of 1 day (range, 1-24). Twenty percent required new scheduled psychiatric medications while in the ICU, and 8.1 % of patients were discharged with a newly prescribed antidepressant. Of patients, 15.3 % had consultations with psychiatry or social work. Six percent of patients expired, and 18 % had a nontraditional discharge disposition. Overall, 60 % of the patients had at least one recognized risk factor for PICS.
CONCLUSIONS: Given the preponderance of psychiatric disorders and mechanical ventilation during post-operative ICU care in patients with gynecologic cancer, prospective evaluation of risk factors and utility of risk-reducing interventions for PICS is warranted. Long-term cognitive or physical disability is known to hasten mortality; thus, preventative strategies may increase the survival and quality of life for this patient population.

Entities:  

Keywords:  Gynecologic oncology; Intensive care unit; PICS; Post-intensive care syndrome; Psychiatric

Mesh:

Year:  2016        PMID: 27306212     DOI: 10.1007/s00520-016-3305-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  43 in total

1.  Depressive symptoms and impaired physical function after acute lung injury: a 2-year longitudinal study.

Authors:  Oscar J Bienvenu; Elizabeth Colantuoni; Pedro A Mendez-Tellez; Victor D Dinglas; Carl Shanholtz; Nadia Husain; Cheryl R Dennison; Margaret S Herridge; Peter J Pronovost; Dale M Needham
Journal:  Am J Respir Crit Care Med       Date:  2011-12-08       Impact factor: 21.405

2.  Are intensive care factors associated with depressive symptoms 6 months after acute lung injury?

Authors:  David W Dowdy; Oscar Joseph Bienvenu; Victor D Dinglas; Pedro A Mendez-Tellez; Jonathan Sevransky; Carl Shanholtz; Dale M Needham
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

3.  Delirium as a predictor of long-term cognitive impairment in survivors of critical illness.

Authors:  Timothy D Girard; James C Jackson; Pratik P Pandharipande; Brenda T Pun; Jennifer L Thompson; Ayumi K Shintani; Sharon M Gordon; Angelo E Canonico; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  Crit Care Med       Date:  2010-07       Impact factor: 7.598

4.  One-year trajectories of care and resource utilization for recipients of prolonged mechanical ventilation: a cohort study.

Authors:  Mark Unroe; Jeremy M Kahn; Shannon S Carson; Joseph A Govert; Tereza Martinu; Shailaja J Sathy; Alison S Clay; Jessica Chia; Alice Gray; James A Tulsky; Christopher E Cox
Journal:  Ann Intern Med       Date:  2010-08-03       Impact factor: 25.391

5.  Risk factors for depression and anxiety in survivors of acute respiratory distress syndrome.

Authors:  Ramona O Hopkins; Colin W Key; Mary R Suchyta; Lindell K Weaver; James F Orme
Journal:  Gen Hosp Psychiatry       Date:  2009-12-14       Impact factor: 3.238

6.  One-year outcomes in survivors of the acute respiratory distress syndrome.

Authors:  Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

7.  Predictors of extended intensive care unit resource utilization following surgery for ovarian cancer.

Authors:  Teresa P Díaz-Montes; Mariana L Zahurak; Robert E Bristow
Journal:  Gynecol Oncol       Date:  2007-08-31       Impact factor: 5.482

8.  Intensive care unit hypoglycemia predicts depression during early recovery from acute lung injury.

Authors:  David W Dowdy; Victoriano Dinglas; Pedro A Mendez-Tellez; O Joseph Bienvenu; Jonathan Sevransky; Cheryl R Dennison; Carl Shanholtz; Dale M Needham
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

9.  Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors.

Authors:  Stephanie A Reid-Arndt; Albert Yee; Michael C Perry; Catherine Hsieh
Journal:  J Psychosoc Oncol       Date:  2009

10.  Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.

Authors:  Lisa M Hess; Helen Q Huang; Alexandra L Hanlon; William R Robinson; Rhonda Johnson; Setsuko K Chambers; Robert S Mannel; Larry Puls; Susan A Davidson; Michael Method; Shashikant Lele; Laura Havrilesky; Tina Nelson; David S Alberts
Journal:  Gynecol Oncol       Date:  2015-10-09       Impact factor: 5.482

View more
  1 in total

Review 1.  Postoperative Admission in Critical Care Units Following Gynecologic Oncology Surgery: Outcomes Based on a Systematic Review and Authors' Recommendations.

Authors:  Nikolaos Thomakos; Anastasia Prodromidou; Dimitrios Haidopoulos; Nikolaos Machairas; Alexandros Rodolakis
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.